ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ESTABLISHMENT LABS HOLDINGS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$58.26−0.92 (-1.55%)
Close on Oct 19, 2026
- Market cap
- $1.75B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$10.99 (+23.26%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ESTABLISHMENT LABS HOLDINGS INC. grew revenue 38.6% to $245.82M over the twelve months to Jun 30, 2026. Free cash flow was -$41.51M.
Revenue
$245.82M
+38.6% vs. a year earlier
Operating income
-$18.76M
TTM Q2 2026
Free cash flow
-$41.51M
TTM Q2 2026
EPS, diluted
-$1.31
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.75B
- P/E ratio
- –
- Price to sales
- 7.14
- Price to book
- 81.22
- Dividend yield
- –
- Free cash flow yield
- -2.37%
Fundamentals
- Revenue
- $245.82M
- Net income
- -$38.89M
- EPS, diluted
- -$1.31
- Free cash flow
- -$41.51M
- Book value per share
- $0.72
- Diluted shares
- 30M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
$245.82M+38.6% YoY
Gross profit
$173.27M+45.3% YoY
Operating income
-$18.76M
Net income
-$38.89M
EPS, diluted
-$1.31
Free cash flow
-$41.51M
Reported periodTrailing twelve months